Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study

Emapalumab-containing regimens stabilized or normalized most key laboratory parameters, reduced glucocorticoid dose, and were associated with low disease-related mortality, thereby demonstrating potential benefits in patients with rheumatologic disease-associated HLH.

Authors

Institutions

Publication Details

Journal
Arthritis & Rheumatology
Published
2024-09-09
DOI
https://doi.org/10.1002/art.42985
Citations
15
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
6.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study

Michelle L. Hermiston, Susmita N. Sarangi, Carl E. Allen, Mona Riskalla et al.
15 citations
Arthritis & Rheumatology
Autoimmune and Inflammatory Disorders Research
6.82
article

Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study

Michelle L. Hermiston, Susmita N. Sarangi, Carl E. Allen, Mona Riskalla, Abiola Oladapo, Renee Modica, John Carter, Anand Tandra, Lauren Draper, Adi Zoref‐Lorenz, May Chien, Michael S. Isakoff, Deepika Bhatla, Shanmuganathan Chandrakasan, Sachit Patel, J. Allyson Hays, Kelly Walkovich, Michael B. Jordan, Prakash Satwani, Rabi Hanna, Priti Pednekar, Taizo A. Nakano, Edward M. Behrens, Patricia M. Hobday, Olive S. Eckstein, Jennifer W. Leiding, John Yee, Ashley P. Hinson, Robert B. Cooper
article en
15 citations

Abstract

Emapalumab-containing regimens stabilized or normalized most key laboratory parameters, reduced glucocorticoid dose, and were associated with low disease-related mortality, thereby demonstrating potential benefits in patients with rheumatologic disease-associated HLH.

Arthritis & RheumatologyVol. 77(2)
Cincinnati Children's Hospital Medical Center (US), Cleveland Clinic (US), Children's Mercy Hospital (US), Lucile Packard Children's Hospital (US), Children's Hospital of Philadelphia (US), NewYork–Presbyterian Hospital (US), Johns Hopkins University (US), Emory University (US), Tel Aviv University (IL), Oregon Health & Science University (US), University of California, San Francisco (US), Baylor College of Medicine (US), Georgetown University (US), University of Michigan (US), Columbia University Irving Medical Center (US), Johns Hopkins Medicine (US), University of Florida Health (US), Texas Health Dallas (US), New York Hospital Queens (US), Meir Medical Center (IL), Flower Hospital (US), MedStar Georgetown University Hospital (US), Children's Hospital Colorado (US), Johns Hopkins All Children's Hospital (US), Franciscan Health Indianapolis (US), Connecticut Children's Medical Center (US), Aflac (United States) (US), Precision for Medicine (United States) (US), Mercy Hospital (US), Levine Children's Hospital (US), University of Minnesota Medical Center (US), Children's Healthcare of Atlanta (US), Saint Louis University (US), University of Nebraska Medical Center (US), University of Florida Health Science Center (US), University of Cincinnati (US), University of Cincinnati Medical Center (US), University of Colorado Denver (US)
Swedish Orphan Biovitrum
Good health and well-being
Openalex Percentile: Top 3%
Autoimmune and Inflammatory Disorders Research
6.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.